Finance

Beta
Lists
603229:SHA
Zhejiang Ausun Pharmaceutical Co Ltd
CN¥8.94
+0.22%
(+0.020) 1D
Jun 10, 3:00:05 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603229...
Open
CN¥8.93
High
CN¥8.99
Low
CN¥8.77
Mkt. cap
7.41B
Avg. vol.
12.70M
Volume
6.28M
P/E ratio
68.14
52-wk high
CN¥12.51
52-wk low
CN¥8.48
EPS
CN¥0.13
Shares outstanding
160.00M
No. of employees
1K
Open
CN¥8.93
High
CN¥8.99
Low
CN¥8.77
Mkt. cap
7.41B
Avg. vol.
12.70M
Volume
6.28M
P/E ratio
68.14
52-wk high
CN¥12.51
52-wk low
CN¥8.48
EPS
CN¥0.13
Shares outstanding
160.00M
No. of employees
1K
News stories
From sources across the web
About Zhejiang Ausun Pharmaceutical Co Ltd
CEO-
Employees1.33K
FoundedApr 22, 2010
Headquarters-
SectorPharmaceutical industry
Websiteausunpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
175.24M
164.09M
146.80M
308.67M
Cost of goods sold
84.05M
74.64M
109.90M
116.10M
Cost of revenue
84.05M
74.64M
109.90M
116.10M
Research and development expenses
28.03M
25.28M
86.27M
30.76M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.03M
27.19M
43.63M
25.16M
Operating expense
50.56M
51.32M
122.51M
65.26M
Total operating expenses
134.61M
125.96M
232.42M
181.36M
Operating income
40.63M
38.13M
-85.62M
127.32M
Other non operating income
-3.89M
-4.56M
4.51M
-24.03M
EBT including unusual items
57.94M
38.67M
-95.44M
107.33M
EBT excluding unusual items
54.01M
38.79M
-91.98M
110.40M
Income tax expense
7.80M
982.48K
-18.98M
10.67M
Effective tax rate
13.46%
2.54%
19.89%
9.94%
Other operating expenses
3.80M
1.65M
-1.11M
-1.44M
Net income
50.15M
37.69M
-76.46M
96.66M
Net profit margin
28.62%
22.97%
-52.09%
31.32%
Earnings per share
-
-
-
-
Interest and investment income
16.17M
11.95M
12.21M
9.94M
Interest expense
-3.56M
-2.06M
-2.47M
-2.83M
Net interest expenses
12.61M
9.89M
9.74M
7.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
57.87M
53.77M
-67.40M
145.53M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer